Nextage Therapeutics (XTAE:NXTG) Beginning Cash Position : ₪0.40 Mil (As of Jun. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Nextage Therapeutics Beginning Cash Position?

Nextage Therapeutics's Beginning Cash Position for the quarter that ended in Jun. 2024 was ₪0.40 Mil.

Nextage Therapeutics's quarterly Beginning Cash Position declined from Jun. 2023 (₪1.05 Mil) to Dec. 2023 (₪0.00 Mil) but then increased from Dec. 2023 (₪0.00 Mil) to Jun. 2024 (₪0.40 Mil).

Nextage Therapeutics's annual Beginning Cash Position increased from Dec. 2021 (₪2.03 Mil) to Dec. 2022 (₪3.26 Mil) but then declined from Dec. 2022 (₪3.26 Mil) to Dec. 2023 (₪1.05 Mil).

Nextage Therapeutics Beginning Cash Position Historical Data

The historical data trend for Nextage Therapeutics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nextage Therapeutics Beginning Cash Position Chart

Nextage Therapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

0.40

2.03

3.26

1.05

Nextage Therapeutics Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Beginning Cash Position	Get a 7-Day Free Trial										3.26	3.63	1.05	-	0.40

Nextage Therapeutics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Nextage Therapeutics Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Nextage Therapeutics's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Nextage Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nextage Therapeutics Ltd (XTAE:NXTG) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bio-Light, Kiryat Atidim 7, Entrance 1, 2rd Floor, Tel Aviv, ISR, 61581

Website

http://www.m-medic.com

Nextage Therapeutics Ltd is a holding company. The company, through its subsidiaries, is engaged in the development of biological marker, a molecule/gene, which when present in the body at abnormal levels indicates development of a disease. It is focused on the development and commercialization of cancer diagnostic products.

Nextage Therapeutics Headlines

From GuruFocus

First Trust Global Portfolios Limited Announces Name Changes for Certain Sub-Funds of First Trust Global Funds plc

By Business Wire Business Wire • 01-29-2021